| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $85K | -99.3% |
| SG&A Expense | $6.9M | -21.2% |
| Operating Income | -$7.0M | +71.7% |
| Pre-tax Income | -$10.3M | +57.5% |
| Income Tax | -$80K | +0.0% |
| Net Income | -$10.3M | +57.3% |
| EPS (Basic) | -$2.00 | +59.8% |
| EPS (Diluted) | -$2.00 | +59.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.0M | -45.1% |
| Current Assets | $4.1M | -49.2% |
| Total Assets | $7.2M | -43.0% |
| Current Liabilities | $1.5M | -45.1% |
| Total Liabilities | $2.4M | -52.9% |
| Stockholders' Equity | $4.8M | -36.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.0M | +55.9% |
| Investing Cash Flow | $335K | -96.4% |
| Financing Cash Flow | $3.4M | -63.0% |